Global Embolic Protection Devices Market Forecast to 2033
The Global Embolic Protection Devices Market report presents a comprehensive analysis of the Embolic Protection Devices market that offers valuable insights to the investors, stakeholders, and business strategists for the forecast period of 2020-2027. The report on the global Embolic Protection Devices market presents the expected growth rate and market value the market is expected to achieve in the coming years. The report also offers insightful data and recommendations to the market players, emerging players, and stakeholders on how to combat the COVID-19 pandemic. The report offers a comprehensive impact analysis of the pandemic on the Embolic Protection Devices market and its key segments. Furthermore, the report also covers a present and future impact analysis of the pandemic on market growth.
Get a sample of the report @https://www.emergenresearch.com/request-sample/1985
The embolic protection devices market plays a crucial role in preventing complications during cardiovascular procedures by capturing and removing embolic debris that may dislodge during the procedure. These devices are used in interventions such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI). The global embolic protection devices market size was USD 558.0 Million in 2022 and is expected to register a revenue CAGR of 8.3% during the forecast period. The market for embolic protection devices is driven by several factors, including the increasing prevalence of cardiovascular diseases, technological advancements, and the growing adoption of minimally invasive procedures.
The rising prevalence of cardiovascular diseases is a major driver for the embolic protection devices market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths each year. Embolic protection devices help reduce the risk of complications, such as stroke and myocardial infarction, during cardiovascular interventions, improving patient outcomes and reducing healthcare costs.
Technological advancements in embolic protection devices have also contributed to market growth. Manufacturers are continuously innovating to develop devices with improved capture efficiency, ease of use, and compatibility with various procedures. For example, the development of distal filter devices and proximal occlusion devices has enhanced the effectiveness of embolic protection during TAVR and carotid artery stenting procedures.
However, there are certain restraints that may hinder the growth of the embolic protection devices market. One of the major challenges is the high cost associated with these devices. The initial investment, as well as the cost of disposable components, can be significant, particularly for healthcare facilities with limited budgets. This can limit the adoption of embolic protection devices, especially in developing regions.
Another challenge is the lack of reimbursement coverage for these devices in some healthcare systems. Reimbursement policies vary across countries, and the lack of adequate reimbursement can impact the affordability and accessibility of embolic protection devices. Efforts are being made to address this issue and expand reimbursement coverage for these devices.
To provide some statistics, according to a report by the American Heart Association, in the United States, cardiovascular diseases accounted for approximately 836,546 deaths in 2020, representing 1 in 3 deaths. The report also highlights the increasing adoption of minimally invasive procedures, such as TAVR and carotid artery stenting, which require the use of embolic protection devices. [Source: American Heart Association]
In terms of recent product launches, here are a few examples:
- In February 2023, Boston Scientific launched the Sentinel Cerebral Protection System, an embolic protection device designed for use during TAVR procedures. The device captures and removes embolic debris that may be released during the procedure, reducing the risk of stroke.
- In March 2023, Medtronic introduced the Emboshield NAV6 Embolic Protection System, a device used during carotid artery stenting procedures. The device is designed to capture and remove embolic debris, reducing the risk of stroke and improving patient outcomes.
Request a discount on the report @https://www.emergenresearch.com/request-discount/1985
Research Report on the Embolic Protection Devices Market Addresses the Following Key Questions:
- Who are the dominant players of the Embolic Protection Devices market?
- Which regional market is anticipated to have a high growth rate over the projected period?
- What consumer trends and demands are expected to influence the operations of the market players in the Embolic Protection Devices market?
- What are the key growth drivers and restraining factors of the Embolic Protection Devices market?
- What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
- What is the overall impact of the COVID-19 pandemic on the Embolic Protection Devices market and its key segments?
Market Overview:
The report bifurcates the Embolic Protection Devices market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Top competitors of the Embolic Protection Devices Market profiled in the report include:
Medtronic, Boston Scientific Corporation, Abbott, Allium Ltd, Contego Medical, Inc., Edwards Lifesciences Corporation., Innovative Cardiovascular Solutions, LLC., NIPRO, Hologic, Inc., Cardinal Health.
Emergen Research has segmented the global Embolic Protection Devices on the basis of product, fitting, application, and region:
-
Product Outlook (Revenue, USD Million; 2019-2032)
- Distal Filter Devices
- Occlusion Devices
- Proximal Occlusion Filters Devices
-
Material Outlook (Revenue, USD Million; 2019-2032)
- Nitinol
- Polyurethane
-
Application Outlook (Revenue, USD Million; 2019-2032)
- Cardio-vascular diseases
- Neurovascular diseases
- Peripheral vascular diseases
- Coronary artery disease
- Others
Regional Landscape section of the Embolic Protection Devices report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
To know more about the report, visit @https://www.emergenresearch.com/industry-report/embolic-protection-devices-market
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Embolic Protection Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
Request customization of the report @https://www.emergenresearch.com/request-for-customization/1985
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.
Embolic Protection Devices Snapshots
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services